Stockscreener 앱 받기
1.63%
전일 마감가:
$287.81
열려 있는:
$286.95
하루 거래량:
1.57M
Relative Volume:
0.88
시가총액:
$77.13B
수익:
$216.66B
순이익/손실:
$6.25B
주가수익비율:
13.19
EPS:
22.1869
순현금흐름:
$7.44B
1주 성능:
+7.65%
1개월 성능:
+4.85%
6개월 성능:
+5.58%
1년 성능:
-0.93%
1일 변동 폭
$283.19
$296.36
1주일 범위
$273.95
$297.80
52주 변동 폭
$239.51
$350.00
시그나 Stock (CI) Company Profile
명칭
Cigna Group
전화
(860) 226-6000
주소
900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
Compare CI vs UNH, CVS, ELV, HUM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CI
Cigna Group
|
292.76 | 75.83B | 216.66B | 6.25B | 7.44B | 22.19 |
|
UNH
Unitedhealth Group Inc
|
279.28 | 247.49B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CVS
Cvs Health Corp
|
76.37 | 96.10B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
ELV
Elevance Health Inc
|
330.80 | 71.87B | 199.13B | 5.66B | 3.17B | 25.11 |
|
HUM
Humana Inc
|
177.62 | 21.81B | 126.36B | 1.30B | 1.55B | 10.67 |
시그나 Stock (CI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-14 | 개시 | Goldman | Buy |
| 2025-02-06 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2024-06-26 | 개시 | Piper Sandler | Overweight |
| 2024-05-30 | 개시 | Robert W. Baird | Outperform |
| 2024-03-06 | 개시 | Barclays | Overweight |
| 2024-02-05 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2024-02-05 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-02-01 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-01-04 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2023-12-11 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-08-18 | 다운그레이드 | Edward Jones | Buy → Hold |
| 2023-06-06 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Neutral |
| 2023-04-05 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-01-03 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-11-23 | 재개 | Morgan Stanley | Overweight |
| 2022-11-21 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2022-07-14 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-06-22 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | 개시 | Loop Capital | Hold |
| 2022-05-27 | 재개 | Bernstein | Mkt Perform |
| 2022-05-26 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-05-16 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-05-09 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2022-02-07 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-02-04 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-01-06 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2021-12-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-12-16 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | 개시 | Goldman | Neutral |
| 2021-11-17 | 개시 | Seaport Research Partners | Buy |
| 2021-09-27 | 개시 | SVB Leerink | Mkt Perform |
| 2021-09-10 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2021-09-10 | 개시 | Cowen | Market Perform |
| 2021-08-06 | 재확인 | BofA Securities | Buy |
| 2021-08-06 | 재확인 | Citigroup | Buy |
| 2021-08-06 | 재확인 | Deutsche Bank | Buy |
| 2021-08-06 | 재확인 | Jefferies | Buy |
| 2021-08-06 | 재확인 | Mizuho | Buy |
| 2021-08-06 | 재확인 | Oppenheimer | Outperform |
| 2021-08-06 | 재확인 | Truist | Buy |
| 2021-05-19 | 개시 | Wells Fargo | Equal Weight |
| 2020-07-01 | 개시 | SVB Leerink | Mkt Perform |
| 2020-05-04 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2020-03-24 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2019-12-11 | 다운그레이드 | Wells Fargo | Market Perform → Underperform |
| 2019-10-18 | 개시 | Mizuho | Buy |
| 2019-09-30 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2019-09-12 | 개시 | Deutsche Bank | Buy |
| 2019-08-06 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2019-04-23 | 개시 | UBS | Buy |
| 2019-01-14 | 개시 | Stephens | Overweight |
| 2018-12-24 | 개시 | Edward Jones | Buy |
| 2018-03-13 | 개시 | Bernstein | Mkt Perform |
| 2018-03-08 | 개시 | Barclays | Overweight |
| 2018-01-03 | 개시 | Goldman | Neutral |
| 2017-11-03 | 재확인 | RBC Capital Mkts | Outperform |
| 2017-06-22 | 재확인 | RBC Capital Mkts | Outperform |
| 2017-06-12 | 개시 | Credit Suisse | Outperform |
| 2017-06-07 | 개시 | Morgan Stanley | Overweight |
| 2017-05-08 | 재확인 | RBC Capital Mkts | Outperform |
| 2017-04-05 | 개시 | Deutsche Bank | Buy |
모두보기
시그나 주식(CI)의 최신 뉴스
Mark Cuban Urges Trump To 'Put His Weight Behind' Josh Hawley, Elizabeth Warren's 'Break Up Big Medicine Act' - Benzinga
This Week's Healthcare Earnings: Lilly, Cigna And More - Law360
How Investors Are Reacting To Cigna Group (CI) Earnings Beat, Massive Buybacks And Dividend Hike - Yahoo Finance
Cigna to lay off 2,000 workers worldwide - Healthcare Dive
Cigna to Remedy Years of Unfair Business Practices with Patients and Pharmacies - Drug Topics
Cigna to cut 2,000 jobs - Healthcare Finance News
Deutsche Bank Aktiengesellschaft Forecasts Strong Price Appreciation for Cigna Group (NYSE:CI) Stock - MarketBeat
Deutsche Bank Raises Price Target on Cigna Group to $304 From $301, Keeps Buy Rating - marketscreener.com
Cigna Group $CI Shares Acquired by Oppenheimer Asset Management Inc. - MarketBeat
Providence Capital Advisors LLC Acquires 7,748 Shares of Cigna Group $CI - MarketBeat
Cigna to cut 2,000 positions this month - Modern Healthcare News
Cigna Healthcare Returns as Title Sponsor of the Denver Colfax Marathon - Endurance Sportswire
The Cigna Group Named Top Dividend Stock With Insider Buying and 2.14% Yield (CI) - Nasdaq
CI: TD Cowen Raises Price Target for Cigna Group to $338 | CI St - GuruFocus
Landmark Settlement: The Cigna Group Resolves FTC Insulin Pricing Suit, Reshaping the PBM Landscape - FinancialContent
Cigna Stock: Is Wall Street Bullish or Bearish? - Barchart.com
Present Moments Recovery Now In-Network with Cigna & Evernorth Be - The National Law Review
TD Cowen Maintains Cigna Group(CI.US) With Buy Rating, Raises Target Price to $338 - 富途牛牛
Jefferies Adjusts Price Target on Cigna to $333 From $310, Maintains Buy Rating - marketscreener.com
TD Cowen Adjusts Price Target on Cigna to $338 From $333, Maintains Buy Rating - marketscreener.com
A Look At Cigna Group (CI) Valuation After Earnings Beat Dividend Hike And FTC Settlement - simplywall.st
There's Been No Shortage Of Growth Recently For Cigna Group's (NYSE:CI) Returns On Capital - Yahoo Finance
Cigna FTC Settlement Reshapes Express Scripts Model And Investor Outlook - simplywall.st
Bloomfield-based health-care giant Cigna Group and FTC settle insulin-price lawsuit - CT Insider
Cigna Executives See Little ’26 Movement in Enrollment, Cost Ratio - HCI Innovation Group
Cigna Group (CI) Analyst Rating Update: RBC Capital Maintains wi - GuruFocus
FTC Deal Reshapes Cigna’s Express Scripts Margins And PBM Positioning - simplywall.st
News | Insurance giant Cigna sheds half of its downtown Philadelphia hub - CoStar
Is The Cigna Group Gaining or Losing Market Support? - Benzinga
Cigna Shows Greater Stability Amid Policy Uncertainty, RBC Says - marketscreener.com
Cigna Group (CI) Buy Rating Maintained by Guggenheim with Increa - GuruFocus
Cigna Group (CI) Analyst Rating: Barclays Lowers Price Target | - GuruFocus
BofA Securities Maintains Cigna Group(CI.US) With Buy Rating, Maintains Target Price $378 - 富途牛牛
RBC Trims Price Target on Cigna Group to $333 From $344, Keeps Outperform Rating - marketscreener.com
Cigna Corporation (NYSE:CI) Q4 2025 Earnings Call Transcript - Insider Monkey
CI Q4 Deep Dive: PBM Model Transition and Specialty Growth Drive Positive Results - Finviz
Cigna Group Q4 Earnings Call Highlights - Yahoo Finance
Cigna posts US$6 billion profit on double‑digit 2025 revenue growth - Insurance Business
Cigna posts $6 billion profit on double‑digit 2025 revenue growth - Insurance Business
FTC, Cigna settle PBM insulin lawsuit - Modern Healthcare News
Cigna’s Reassurances About PBM Business Lift Stock - The Wall Street Journal
Cigna beats quarterly estimates, provides muted outlook | Business Information & News | FE - Westlaw Today
Cigna Earnings Call: Growth Holds Amid PBM Overhaul - TipRanks
The Cigna Group (CI) Q4 2025 Earnings Call Highlights: Strong Re - GuruFocus
The Cigna Group (CI) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Website Wiretapping Claims Trimmed From Cigna Suit - Law360
CignaContinued Downside In 2026E (NYSE:CI) - Seeking Alpha
The Cigna Group (CI) Stock Price Up 2.81% on Feb 5 - GuruFocus
Cigna hails pharmacy deal with the FTC, battles elevated cost trends - InsuranceNewsNet
Cummins Revenue Holds Up as Charges Weigh on Near-Term Earnings Clarity - Investing.com
3 takeaways from Cigna’s 2025 earnings call - Managed Healthcare Executive
시그나 (CI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.58%
1.93%
자본화:
|
볼륨(24시간):